Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
about
Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseTargeting metabolism in breast cancer: How far we can go?ROS homeostasis and metabolism: a critical liaison for cancer therapyInhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.The oncogenic potential of human cytomegalovirus and breast cancer.Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells.Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugsGlucose transporter isoform 1 expression enhances metastasis of malignant melanoma cellsPerspectives of the AMP-activated kinase (AMPK) signalling pathway in thyroid cancer.Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.The metabolic landscape of cancer stem cells.Sorafenib for the treatment of breast cancer.Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib.AMP-activated protein kinase - not just an energy sensor.Downregulation of stanniocalcin 1 is responsible for sorafenib-induced cardiotoxicity.Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells.
P2860
Q26745320-C9FCF67E-971D-4371-94C9-15B78421EB74Q26767022-FB0BD1F1-9DB1-42FB-B3D8-BC7B3CF111A2Q28080316-D04BD988-0FDA-4AD1-8D31-48FFDC8518F0Q33728138-982DDD15-FB29-49BD-97E4-792779879D25Q34081724-F339B148-B9C7-4C08-A738-0D58CCD97A0FQ34466148-9A1363F0-BA60-471C-BA5B-2BADF93A9340Q35035126-17892F64-5924-4392-B82B-047FCE5337BFQ35183284-56B5CE72-3661-45E4-86C1-564F2E73E213Q36413738-25D90C88-4348-4C53-A808-E7D1BB5D22C1Q36544964-1EB7A1F6-8EAA-4AEC-992E-634E99F370DEQ37702988-81E59733-F349-4268-8F26-61C7751C6300Q37746021-9D389B93-4BE5-4DD1-ABDA-DDDDE831F4B0Q38580323-1BBA6C95-67A0-40B9-9BD1-437D02360B8EQ38881805-ADDC209D-69CE-4331-87B8-ADC6E3379D1FQ41095164-5DF989C9-1FFA-4559-98FA-10208981F1C5Q42364792-FA048C8D-3B38-4884-BDBA-112C2A3666FEQ42703704-8A4193FA-7FB3-472B-A447-8836E49830A6Q47135891-8E6F4F34-F557-4F94-B7E0-EFFB7ACF140FQ55091523-F0620883-EE3A-407E-AD2A-6036F5D5A55C
P2860
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of sorafenib on energy ...... role of AMPK-mTORC1 signaling.
@en
Effects of sorafenib on energy ...... role of AMPK-mTORC1 signaling.
@nl
type
label
Effects of sorafenib on energy ...... role of AMPK-mTORC1 signaling.
@en
Effects of sorafenib on energy ...... role of AMPK-mTORC1 signaling.
@nl
prefLabel
Effects of sorafenib on energy ...... role of AMPK-mTORC1 signaling.
@en
Effects of sorafenib on energy ...... role of AMPK-mTORC1 signaling.
@nl
P2093
P2860
P50
P1476
Effects of sorafenib on energy ...... role of AMPK-mTORC1 signaling.
@en
P2093
Elena Galvani
Mara A Bonelli
Pier Giorgio Petronini
Roberta R Alfieri
Silvia La Monica
P2860
P2888
P356
10.1007/S10549-013-2668-X
P407
P577
2013-08-21T00:00:00Z